Patterns of genome dynamics and cancer evolution *
To the Editor,
The importance of the chromosome versus the gene as a causative agent in cancer formation has sparked a heated debate. This issue is directly related to two different schools of thought, namely the gene-centric or genome-centric paradigms of cancer research [1] [2] [3] . For decades we have essentially ignored the evolutionary nature of complex cancer systems due to the influence of reductionist viewpoints and experimental approaches. Cancer research has focused on identifying and characterizing the step-wise accumulation of gene mutations and the consequent effects on the corresponding pathways, as the cancer evolutionary process has been thought by many as a linear and predictable process. Despite the fact that chromosome aberrations are nearly universally detected in cancer cases, the gene-centric viewpoint has led to the conclusion that chromosome aberrations are a consequence of gene mutations and therefore must be late events. Furthermore, chromosomal research has focused on the identification of recurrent types of clonal chromosome aberrations (CCAs). Specific patterns of these clonal events have been utilized both in clinical diagnosis and treatment. However, due to hyper-focus on identifying recurrent changes, the true karyotypic heterogeneity of cancer has been under appreciated, with non-recurrent change being considered "genetic noise", which has been largely ignored [4] . Recently, the existence of an overwhelming amount of non-clonal chromosome aberrations (NCCAs), the major form of genome variation and the key index for system instability, has been identified in patients and cancer progression models [5, 6] .
The study of chromosomes in cancer has also been considered a low resolution approach compared with molecular methods such as DNA sequencing and thus was said to not offer causative insight. How-* This work was presented at the 2nd Conference on Aneuploidy and Cancer, Oakland, January 31- February 3, 2008. ever, mounting evidence (including the failure to identify a number of common causative gene mutations from large scale gene sequencing) shows that the long sought handful of mutated cancer causing genes does not exist [7, 8] . This surprising finding is explained (and in fact has been predicted) through our demonstration that the stochastic karyotypic/genetic variation drives cancer progression and that cancer evolution through natural selection is mainly mediated by stochastic genome variation [2, 6] . This crucial conclusion shows that cancer should be treated as an unpredictable evolutionary process of a complex system. These realizations challenge the strategies of solely pushing for higher resolution to/at the molecular level. From a complex system point of view, focusing on the details of the lower level (genes) might not reveal the emergent properties at the higher level (genome). Even at the lower level, the detected causative relationship is only meaningful within an isolated experimental setting (an isolated pathway) but may not be applicable to an entire genome system (when various pathways interact).
We have demonstrated that karyotypic evolution is a universal feature detected during the changes in the key status of system progression such as immortalization, transformation, metastasis and drug resistance. Thus, we have proposed a genome-centric concept for cancer and organismal evolution [9] [10] [11] . Specifically, genome level variation represents genetic alteration at the highest, broadest reaching level of genetic organization. The genome context (defined as an entire set of genes/regulatory elements and their physical distribution along chromosomes) and not individual genes define a given system. The genome (not individual genes) is the unit of macro-evolution and the cancer related somatic evolution platform also exists mainly at the genome level. There are many genetic, epigenetic and non-genetic factors that can trigger system instability and initiate the cancer evolutionary process. However, evolutionary force selects a package deal based on genome context rather than individual genes, and
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it is the genome context that determines the boundary of potential genetic and epigenetic response to system stress. Interestingly, the two phases of evolution (a stochastic phase and a stepwise phase) can be detected during the same cancer evolutionary process (depending on the overall stability and growth characteristics of the system) and the patterns of karyotypic evolution can be used for diagnosis as well as studying the mechanism of cancer and organismal evolution [9] [10] [11] .
To support the genome-centric concept of cancer evolution, we have shown that chromosomal changes determine a global pattern of gene expression by the use of gene expression signatures coupled with karyotype analysis of an in vitro cancer model. We have further illustrated the concept that the genome context (which defines the genetic network) and not the gene content define a given genetic system, as the expression patterns are defined by the genome context coupled with the effects of different gene mutations. Interestingly, shortly after many drug treatments, extreme karyotypic change (karyotypic chaos) is detectable and is an important mechanism for the induction of drug resistance as it represents an effective way for karyotypic evolution to occur. To further illustrate the importance of genome level alterations in cancer evolution, we have also shown a number of new chromosomal aberrations including defective mitotic figures (DMFs) and chromosome fragmentation which illustrate how genome instability (through changed genome context) play a role in generating population heterogeneity that contributes to cancer evolution [5, 12, 13] . Our data suggests that cancer is a disease of probability [2] , and that cancer evolution is mainly driven by instability mediated genome variation as the somatic evolutionary platform exists mainly at the genome level (stochastic gene mutation may in fact be by-stander consequences of genome dynamics). As genomic instability itself represents a major factor that promotes cancer evolution, cancer research should focus on the complex mechanism of controlling overall genome instability rather than focusing on a specific set of gene mutations. This statement is further supported by our discovery that there is a major conflict between genes and the genome [10, 11] . Comparisons of the patterns of somatic evolution and organismal evolution strongly support this concept.
